About Enveda Biosciences
Enveda Biosciences is a drug discovery company that leverages artificial intelligence and advanced chemistry to unlock the medicinal potential of the natural world. The company has developed a proprietary platform that can read and translate nature's hidden chemistry at unprecedented speed and scale, addressing a fundamental challenge in pharmaceutical research: nearly half of all medicines in pill form originate from molecules found in nature, yet almost the entirety of the natural world remains a chemical mystery due to the time and cost of purifying, identifying, and characterizing individual molecules from complex mixtures. Enveda's technology puts billions of years of evolutionary intelligence into the hands of drug hunters, enabling the discovery of medicines 4X faster than the industry average. The company's mission is to give hope to millions of people worldwide by accelerating the discovery of better, life-saving and life-enhancing medicines. With operations in Boulder, Colorado and Hyderabad, India, Enveda is building a pipeline of novel therapeutics derived from nature's vast chemical library.
Mission & Story
Mission
Enveda exists to give hope to millions of people around the world by accelerating the discovery of better medicines
Who It Serves
Milestones & Awards
Recent Milestones
Company has established operations in both Boulder, CO and Hyderabad, India; actively building drug pipeline
Social & Media
Latest Updates
Survival of the Fittest: Nature’s Solution to Surviving Clinical Trials
In-Veda: Insights into Enveda. Insights into knowledge.
Rediscovering Therapeutic Roots: How Ethnobotany Aids Drug Discovery
Breaking Barriers: Simultaneous Target and Drug Discovery at Scale
Artemisinins, Malaria, and The Quest to Systematize Collaboration between Nature and Scientists (Cures and Nobel Prizes)
Company Details
- Headquarters
- Boulder, CO, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.